| Value | ₹0.35 Cr |
|---|
BSE filing, NSE: CEATLTD. Summary written from the filing by ALFA Finder's alert engine.
Ceat Ltd: key numbers
- Share price
- ₹3,134.70
- Market cap
- ₹12,680 Cr
- Revenue (annual)
- ₹15,678 Cr
- Net profit (annual)
- ₹698.0 Cr
- P/E (TTM)
- 24.6×Sector 30.9×
- Promoter holding
- 47.29%+0.00% QoQ
- FII holding
- 13.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ceat Ltd
All →Ceat Debt & Borrowing: ₹50 Cr
CEAT Limited confirmed redemption of its Rs. 50 Crore Commercial Paper on maturity dated October 23, 2026. The scheduled obligation was fulfilled on the same day.
- Value
- ₹50.00 Cr
Ceat Other Announcement
CEAT Ltd disclosed loss of three share certificates belonging to holder G Sudarshan Pal. NSDL notified the exchanges for member reference and duplicate issuance.
Ceat Earnings Call Transcript: Key Takeaways
Ceat achieved record quarterly revenue but margins are under pressure from rising input costs and currency depreciation. Management is aggressively expanding capacity while navigating a complex transition with the Camso acquisition.
Ceat Investor Presentation: Key Takeaways
CEAT reported Q2 FY27 revenue of Rs. 4,762 Cr, up 26.2% YoY, driven by healthy volume and realization growth across segments despite EBITDA margin contraction due to raw material costs.
Ceat Management Change
CEAT Limited has appointed Mr. Sumeet Narang as a Non-Executive Independent Director for a 5-year term, effective October 14, 2026.
Ceat Q2 FY27 Results: Net Profit ₹112 Cr, Down 39.8% YoY
Ceat Ltd reported revenue from operations of ₹4,762 Cr (+26.2% YoY) and net profit of ₹112 Cr (-39.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹112 Cr · -39.8% YoY
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.